Advanced Sterile Product Preparation Training and Certificate Program

Size: px
Start display at page:

Download "Advanced Sterile Product Preparation Training and Certificate Program"

Transcription

1 Advanced Sterile Product Preparation Training and Certificate Program ACPE Activity Number(s): H04-P & T thru to H04-P & T Release Date: November 7, 2016 Expiration Date: November 7, based CE Credit Hour(s) (no partial credit): 23.0 hours Accreditation for Pharmacists and Pharmacy Technicians The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Target Audience This program is intended for pharmacists, pharmacy technicians, or other pharmacy personnel who have responsibility for managing and developing competent cleanroom personnel and/or compliant compounding facilities. Activity Overview These modules are designed for participants who have mastered and are proficient in the fundamental skills required for safe and compliant sterile product preparation in a cleanroom environment and are now responsible for managing personnel and facilities associated with these compounding activities. Participants will recognize the many considerations required when developing competent personnel and designing appropriate environments and facilities for compliant sterile product preparation. After completing all of the modules, participants should be proficient in both basic compounding techniques and advanced concepts required for managing safe and compliant sterile product preparation in a cleanroom environment. Learning Objectives and Schedule of Activities H04-P H04-T CE Hours: 2.0 Title: Beyond the Basics: The Role Management Plays in Ensuring Safe and Compliant Sterile Product Preparation This activity explains the key concepts managers must consider to effectively develop competent personnel and compliant facilities for sterile product preparation. Identify the critical USP chapter 797 elements managers must know in order to manage cleanroom facilities and personnel. Explain the basic personnel competencies required to ensure safe and compliant sterile product preparation. Recognize the key role pharmacy leaders have in creating a culture supporting safe and compliant compounded sterile product preparation. Describe how to implement a continuous learning plan for all staff engaged in sterile product preparation. Page 1

2 H04-P H04-T CE Hours: H04-P H04-T CE Hours: H04-P H04-T CE Hours: 2.5 Title: Creating and Maintaining the Right Environment This activity describes the appropriate environment for sterile product preparation and the processes required to maintain it. Restate the environmental requirements for sterile compounding. Explain how environmental conditions are measured and maintained. Discuss how to respond to environmental samples that are out of range. Define and determine how to properly perform surface sampling. Describe the process for how to properly perform volumetric air sampling. Discuss how to build environmental control / monitoring skills into the compounded sterile preparation training program. Title: Facilities and Equipment This activity covers the requirements and maintenance for cleanroom facilities and equipment. Describe primary and secondary engineering controls used in compounding facilities. Identify sterile compounding facility requirements. Discuss essential cleanroom design considerations and compare advantages and disadvantages of available finish materials. Explain selection criteria and appropriate placement of ancillary equipment such as refrigerators, computers, and printers. Recognize automated devices used in compounding sterile products. Describe equipment and cleanroom certification and maintenance requirements. Explain how to develop a plan to accommodate cleanroom or equipment downtime and upgrades. Identify considerations for designing a facility cleaning plan. Title: Developing Personnel for Success in the Cleanroom This activity explains the essential role appropriately trained personnel play in ensuring safe and compliant sterile product preparation. Discuss differences between ISO environments. Describe the purpose of the HEPA Filter Leak Test and Smoke Pattern Testing. Explain the concept of first air and associated hand placement in horizontal and vertical flow hoods. Discuss the differences between appropriate garbing requirements for non-hazardous and hazardous drug preparation. Describe personnel testing and associated outcomes. Explain the processes for low, medium (category 1), and high-risk (category 2) media fill testing. Discuss techniques used for teaching adult learners. Explain how to create an action plan for sub-optimal performance. Identify staff scheduling plan considerations. Page 2

3 H04-P H04-T CE Hours: H03-P H03-T CE Hours: 2.5 Title: Managing the Product from the Beginning to the End This activity describes important considerations associated with effectively managing materials flow from receiving through to the finished product. Describe the materials flow process from receiving to finished product. Explain standards for selection of ingredients and other products used in sterile compounding. List cold-chain requirements for refrigerated products. Discuss material handling requirements for items going into a cleanroom. Recognize storage requirements for all drugs and materials used in sterile compounding. Describe packaging and transport requirements for finished compounded sterile products. Identify considerations in beyond use date (BUD) assignment. Discuss strategies for managing expired and unusable compounded sterile preparations. Title: Legal, Regulatory, and Quality Control This activity covers the regulatory and quality control guidance required to ensure safe and compliant sterile product preparation. Describe the scope and implementation of the Drug Quality and Safety Act (DQSA) with respect to compounding quality. Discuss the guidances issued by the FDA for 503A operations. Explain how section 503B in the Food, Drug, and Cosmetic Act allows for outsourcing facilities. Recognize the guidance documents issued for 503B facilities. Describe the requirements for dispensers under the Drug Supply Chain Security Act. List resources that provide current information on state pharmacy laws, regulations, and accreditation standards. Identify the basic quality control differences between USP chapter 797 and current Good Manufacturing Practices (cgmp). Describe an effective quality assurance / quality control program based on risk assessment. Discuss the criteria and tests employed to evaluate and certify performance of facility and environmental controls used for compounding sterile preparations. Page 3

4 H04-P H04-T CE Hours: H04-P H04-T CE Hours: 1.0 Title: Hazardous Drugs 101 This activity discusses the appropriate guidelines and procedures required to handle and manage hazardous drugs in a safe and compliant manner. Restate the goals of USP Chapter <800>. Describe the Hazardous Drug Risk Assessment process. List information available on a Safety Data Sheet. Recognize hazardous drug activity and potential opportunities for exposure. List the requirements for hazardous drug receiving, unpacking and storage. Describe appropriate receipt, storage, labeling, packaging, transport, and disposal of hazardous drugs. Explain the gowning and gloving process required for hazardous drug compounding. List and define primary, secondary and supplemental engineering controls. List the steps involved in cleaning a biological safety cabinet (BSC) and compounding aseptic containment isolator (CACI). Discuss the hazardous drug surface wipe sampling process. Describe the hazardous drug spill clean-up process. Discuss OSHA's Hazard Communication Standard. Explain the purpose and elements of the Medical Surveillance Program. Title: Introduction to Nonsterile to Sterile Compounding This activity explains the general requirements and considerations associated with nonsterile to sterile compounding. Explain the requirements under section 503A of the Drug Quality and Safety Act that apply to bulk drug ingredients. Identify the requirements under chapter 797 for nonsterile to sterile compounding. Discuss the facility and environmental requirements for nonsterile to sterile compounding. Restate product release requirements for nonsterile to sterile compounding. List the critical quality attributes for a compounded sterile preparation that must be within limits to guarantee required product quality. Describe the installation and operational validation process for sterilization equipment. Explain chapter 797 guidance on beyond use dating. Recognize the components of quality control. Page 4

5 H04-P H04-T CE Hours: 3.0 Title: Additional Considerations for the Manager This activity discusses management considerations uniquely associated with preparing compounded sterile products in a safe, efficient, and compliant manner. Describe the key considerations for successful management of sterile compounding operations. Discuss the actions required to appropriately assess current clean room facilities. Explain the key policies and procedures that need to be in place in order to achieve USP chapter 797 and USP chapter 800 compliance. Discuss the value and implications of developing and maintaining a master formulary record. Identify a contingency plan in the event of environmental control downtime or failure. List the key variables and decision points when evaluating outsourcing compounded sterile preparations. Describe the process that must be utilized to evaluate outsourced compounded sterile preparation (CSP) providers. Discuss the implications and challenges of managing CSP operations in a multi-site system. Recognize lean management opportunities in CSP operations. Identify the types of knowledge that c-suite leaders need to have in regard to USP chapter 797 and USP chapter 800. Methods and CE Requirements This online activity consists of a combined total of 9 learning modules. Pharmacists and pharmacy technicians are eligible to receive a total of 23.0 hours of continuing education credit by completing all 9 modules within this certificate program. Participants must participate in the entire activity and complete the evaluation to earn continuing pharmacy education credit. Follow the prompts online at the ASHP elearning portal ( to claim credit and view statements of credit within 60 days of completing the activity. Credits will be reported directly to CPE Monitor. Faculty Information Matthew W. Eberts, Pharm.D., M.B.A, FASHP Director of Pharmacy Services Lancaster General Health Lancaster, PA Lisa Ginsberg-Evans, B.S. Pharm Manager, Clean Room and Sterile Products University of Michigan Hospitals and Health System Clinical Instructor University of Michigan College of Pharmacy Ann Arbor, MI Marc Stranz, Pharm.D. Vice President of Compliance Elwyn Pharmacy Group Garnet Valley, PA Page 5

6 Angela W. Yaniv, B.S.Pharm, Pharm.D. Assistant Director of Pharmacy Cleveland Clinic Cleveland, OH CE Activity Announcement Disclosures In accordance with the Accreditation Council for Continuing Medical Education s Standards for Commercial Support and the Accreditation Council for Pharmacy Education s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his/her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content In keeping with this requirement, ASHP asks that all faculty, advisory board members, planning committee members, content development consultants, and staff complete a disclosure form for each program in which they are involved. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. Faculty, planners, ASHP Staff and consultants report no relevant financial relationships pertinent to this activity. Matthew W. Eberts, Pharm.D., M.B.A., FASHP Lisa Ginsberg-Evans, B.S. Pharm Marc Stranz, Pharm.D. Angela W. Yaniv, B.S.Pharm, Pharm.D. Jill L. Haug, Pharm.D., M.B.A. Alicia M. Ross, B.S. ASHP staff has no relevant financial relationships to disclose. Acknowledgements of Support (if applicable) This activity was planned and developed by The American Society of Health-System Pharmacists. Page 6

Compounded Sterile Preparations Pharmacy Content Outline May 2018

Compounded Sterile Preparations Pharmacy Content Outline May 2018 Compounded Sterile Preparations Pharmacy Content Outline May 2018 The following domains, tasks, and knowledge statements were identified and validated through a role delineation study. The proportion of

More information

Implementing USP

Implementing USP Implementing USP 800 Joanna Robinson, PharmD, MS Inpatient Operations Manager Disclosure I have no conflicts of interest to disclose Objectives 1. Understand the purpose of USP 80 2. Describe how to engage

More information

11/4/2016. Sterile Compounding: USP<797> Revisions and the Compounding Quality Act. In the 1930 s and 40 s, 60% of all medications were compounded.

11/4/2016. Sterile Compounding: USP<797> Revisions and the Compounding Quality Act. In the 1930 s and 40 s, 60% of all medications were compounded. Sterile : USP Revisions and the Quality Act Joe Haynes, RPh, CPh, MBA Lead Sterile Products Pharmacist Johns Hopkins All Children s Hospital Objectives: Disclosure: I have no financial interests to

More information

Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS

Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS Disclosure Ashley Duty has no conflicts of interest to disclose Joanna Robinson has no conflicts of interest to disclose Objectives

More information

Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS

Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS Disclosure Ashley Duty has no conflicts of interest to disclose Joanna Robinson has no conflicts of interest to disclose Objectives

More information

USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD

USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL ACTIVITY DESCRIPTION On June 1, 2008, The Revision Bulletin to USP Chapter 797, Pharmaceutical

More information

Understanding USP 797

Understanding USP 797 Baxa Corporation Understanding USP 797 Technical Paper An Overview of USP General Chapter Pharmaceutical Compounding Sterile Preparations Mike Hurst, RPh, MBA 2004 Baxa Corporation Introduction USP

More information

KPIC Aseptic Technique Training Program

KPIC Aseptic Technique Training Program KPIC Aseptic Technique Training Program By registering for this program, you understand and agree that you must complete the home study portion in order to attend the live portion of the program. Upon

More information

PHARMACY SERVICES / MEDICATION USE

PHARMACY SERVICES / MEDICATION USE 25.01.02 Supervision of Pharmacy Activities. In order to provide patient safety, drugs and biologicals must be controlled and distributed in accordance with applicable standards of practice consistent

More information

KPIC Aseptic Technique Training Program Friday, August 24 th Saturday, August 25 th, 2018

KPIC Aseptic Technique Training Program Friday, August 24 th Saturday, August 25 th, 2018 KPIC Aseptic Technique Training Program Friday, August 24 th Saturday, August 25 th, 2018 Registration Deadline: Friday, August 10 th, 2018 at 8:00 am Program Description: The KPIC Aseptic Technique Training

More information

Introduction to USP General Chapter <800> How Will It Affect Federal Pharmacy?

Introduction to USP General Chapter <800> How Will It Affect Federal Pharmacy? CPE Information and Disclosures Introduction to USP General Chapter How Will It Affect Federal Pharmacy? MAJ Jonathan Bartlett Moncrief Army Health Clinic CPT(P) Seth Mayer Walter Reed National Military

More information

6/23/2011. Compounded Sterile Products Update and Review. Learning Goals for the Pharmacist. Learning Goals for the Pharmacy Technician

6/23/2011. Compounded Sterile Products Update and Review. Learning Goals for the Pharmacist. Learning Goals for the Pharmacy Technician Compounded Sterile Products- 2011 Update and Review Jo Ann Gibbs, PharmD Director of Pharmacy Byrd Regional Hospital Leesville, LA Learning Goals for the Pharmacist The pharmacist will be able to: 1. Identify

More information

The Joint Commission Medication Compounding Certification (MDC) FAQs

The Joint Commission Medication Compounding Certification (MDC) FAQs The Joint Commission will be implementing the new Medication Compounding Certification (MDC) program for hospitals, critical access hospitals, and home care pharmacy organizations in the state of Michigan

More information

About OMICS Group Conferences

About OMICS Group Conferences About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of

More information

2018 Pharmacy Education Series

2018 Pharmacy Education Series 2018 Pharmacy Education Series February 21, 2018 2018 Joint Commission Update Featured Speakers: Patricia C. Kienle, RPh, MPA, FASHP Director, Accreditation & Medication Safety Cardinal Health Innovative

More information

Ensuring Readiness for USP Chapter <800> on Handling Hazardous Drugs: Assessment, Planning, and Implementation

Ensuring Readiness for USP Chapter <800> on Handling Hazardous Drugs: Assessment, Planning, and Implementation Ensuring Readiness for USP Chapter on Handling Hazardous Drugs: Assessment, Planning, and Implementation Presented as a Midday Symposium and Live Webinar at the 51 st ASHP Midyear Clinical Meeting

More information

Preventing Occupational Exposure to Hazardous Drugs

Preventing Occupational Exposure to Hazardous Drugs Preventing Occupational Exposure to Hazardous Drugs Teresa (Terry) Fisk, CIH, CSP, Non-Clinical Loss Control Director, IRMS, Trinity Health fiskt@trinity-health.org 734-343-0907 April 12, 2017 Introduction

More information

The Home Infusion Compounder's Guide to the Second Proposed Revision to USP <797>

The Home Infusion Compounder's Guide to the Second Proposed Revision to USP <797> The Home Infusion Compounder's Guide to the Second Proposed Revision to USP By Connie Sullivan PHARMACISTS AND PHARMACY TECHNICIANS This INFUSION article is cosponsored by Educational Review Systems

More information

Sterile Compounding: Highlights of the New Law

Sterile Compounding: Highlights of the New Law Patricia C. Kienle, RPh, MPA, FASHP Director, Accreditation and Medication Safety Cardinal Health Innovative Delivery Solutions Sterile Compounding: Highlights of the New Law 2 Please explain the difference

More information

Sterile Compounding of Hazardous Drugs

Sterile Compounding of Hazardous Drugs Sterile Compounding of Hazardous Drugs Session II Pamella Ochoa, Pharm.D. Jose Vega, Pharm.D. 2 Objectives List requirements of secondary engineering controls for hazardous compounding Explain requirements

More information

USP <797> does not apply to the administration of medications.

USP <797> does not apply to the administration of medications. December 5, 2017 Michael Bullek, BSP, RPh Administrator/Chief of Compliance State of New Hampshire Office of Professional Licensure and Certification Division of Health Professions Board of Pharmacy 121

More information

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER STERILE PRODUCT PREPARATION IN PHARMACY PRACTICE TABLE OF CONTENTS

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER STERILE PRODUCT PREPARATION IN PHARMACY PRACTICE TABLE OF CONTENTS RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-07 STERILE PRODUCT PREPARATION IN PHARMACY PRACTICE TABLE OF CONTENTS 1140-07-.01 Applicability 1140-07-.05 Labeling 1140-07-.02 Standards 1140-07-.06

More information

4/18/2018. Improving USP <800> Compliance in a Community Healthcare Organization. Disclosures. Learning Objectives

4/18/2018. Improving USP <800> Compliance in a Community Healthcare Organization. Disclosures. Learning Objectives Improving USP Compliance in a Community Healthcare Organization Brady Conner, Pharm.D. PGY1 Pharmacy Resident St. Vincent Healthcare, Billings, MT 4/20/1018 Disclosures IRB Status: Exempt Co-investigators

More information

The Impact of FDA s New Compounding Guidance: A Primer. Jillanne M. Schulte, JD ASHP Director of Federal Regulatory Affairs

The Impact of FDA s New Compounding Guidance: A Primer. Jillanne M. Schulte, JD ASHP Director of Federal Regulatory Affairs The Impact of FDA s New Compounding Guidance: A Primer Jillanne M. Schulte, JD ASHP Director of Federal Regulatory Affairs Compounding Recap Drug Quality and Security Act of 2013 Maintained state Boards

More information

The Joint Commission

The Joint Commission The Joint Commission Medication Compounding Certification Michigan Webinar September 8, 2016 GoToWebinar Housekeeping Your Participation Join audio: Choose Mic & Speakers to use VoIP Choose Telephone and

More information

CE Activity Announcement

CE Activity Announcement Medication Safety Certificate Program ACPE Activity Number(s): 0204-9999-17-724-H05-P and T thru to 0204-9999-17-739-H05-P and T Release Date: May 18, 2017 Expiration Date: May 18, 2020 Activity Fee: $395.00/495.00

More information

Clinical IQ, LLC September 2, 2009

Clinical IQ, LLC September 2, 2009 The Top 10 Gaps in USP 797 Compliance Eric S. Kastango, MBA, RPH, FASHP Clinical IQ, LLC September 2, 2009 eric.kastango@clinicaliq.com Disclaimer Although I am a member of the USP Sterile Compounding

More information

1.0 Sterile Compounding Personnel

1.0 Sterile Compounding Personnel Print Version - ASHP Self-Assessment Tool for Compounding Sterile Preparations Thank you for participating in the ASHP Self-Assessment Tool for determining compliance with USP Chapter requirements.

More information

Idaho Pharmacy Law: Developments and Practical Applications

Idaho Pharmacy Law: Developments and Practical Applications Idaho Pharmacy Law: Developments and Practical Applications Alex J. Adams, PharmD, MPH Executive Director Idaho State Board of Pharmacy Alex.Adams@bop.idaho.gov @alexadamsrph In support of improving patient

More information

Compounding Conundrums: Outsourcing Shortages, Clean Room Design, and Hazardous Drugs 2012 Midyear Clinical Meeting

Compounding Conundrums: Outsourcing Shortages, Clean Room Design, and Hazardous Drugs 2012 Midyear Clinical Meeting Disclosures Patricia Kienle reports the following relevant financial relationships Employee of Cardinal Health Compounding Conundrums Outsourcing, Shortages, Clean Room Design, and Hazardous Drugs Luci

More information

The Leader in Guidance for the Health Information Management Profession. Patient Safety Monitor Journal

The Leader in Guidance for the Health Information Management Profession. Patient Safety Monitor Journal The Leader in Guidance for the Health Information Management Profession Patient Safety Monitor Journal Volume 18 Issue No. 1 January 2017 USP : Protecting healthcare workers from hazardous drugs According

More information

Meeting New Requirements for Sterile Compounding Webinar

Meeting New Requirements for Sterile Compounding Webinar Meeting New Requirements for Sterile Compounding Webinar June 28, 2016 CHA Webinar Welcome Liz Mekjavich California Hospital Association 1 Continuing Education Requirements Full attendance, completion

More information

2017 Pharmacy Education Series

2017 Pharmacy Education Series 2017 Pharmacy Education Series March 15, 2017 2017 Joint Commission Update Featured Speakers: Patricia C. Kienle, RPh, MPA, FASHP Terry Baughman Kathryn E. DeSear, PharmD, BCPS, AAHIVP Online Evaluation,

More information

External Assessment Specifications Document

External Assessment Specifications Document External Assessment Specifications Document Curriculum Code: 321301000 Qualification Title: Occupational Certificate: Pharmacy Technician NQF Level: 6 321301000 - Pharmacy Technician External Assessment

More information

C DRUG DISTRIBUTION SYSTEMS

C DRUG DISTRIBUTION SYSTEMS C DRUG DISTRIBUTION SYSTEMS JANET HARDING ORAL MEDICATION SYSTEMS Hospital pharmacy departments are expected to operate drug distribution systems which are safe for the patient, efficient and economical,

More information

Objective Competency Competency Measure To Do List

Objective Competency Competency Measure To Do List 2016 University of Washington School of Pharmacy Institutional IPPE Checklist Institutional IPPE Team Contact Info: Kelsey Brantner e-mail: ippe@uw.edu phone: 206-543-9427; Jennifer Danielson, PharmD e-mail:

More information

Arizona Department of Health Services Licensing and CMS Deficient Practices

Arizona Department of Health Services Licensing and CMS Deficient Practices Arizona Department of Health Services Licensing and CMS Deficient Practices Connie Belden, RN., Bureau of Medical Facility Licensing August 8, 2013 General Comments Deficient Practices per visit Trend

More information

The ACHC-PCAB Pharmacy Accreditation Program

The ACHC-PCAB Pharmacy Accreditation Program CPE CREDIT 1.0 Current & Practical Compounding Information for the Pharmacist VOLUME 19 NUMBER 1 Grant funding provided by Perrigo Pharmaceuticals Goal: To provide information on the importance and procedures

More information

Profiles in CSP Insourcing: Tufts Medical Center

Profiles in CSP Insourcing: Tufts Medical Center Profiles in CSP Insourcing: Tufts Medical Center Melissa A. Ortega, Pharm.D., M.S. Director, Pediatrics and Inpatient Pharmacy Operations Tufts Medical Center Hospital Profile Tufts Medical Center (TMC)

More information

Estimated time to complete activity: 1.5 hours for medical professionals, 3 hours for non medical professionals

Estimated time to complete activity: 1.5 hours for medical professionals, 3 hours for non medical professionals Bloodborne Pathogens INTRODUCTION SECTION 1: Bloodborne Pathogens SECTION 2: Personal Protective Equipment SECTION 3: Disposal, Spills and Cleanup SECTION 4: Tattoo and Piercing Facilities Activity Summary

More information

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

CONSULTANT PHARMACIST INSPECTION LAW REVIEW CONSULTANT PHARMACIST LAW REVIEW Florida Consultant Pharmacist s are required in: a. Class I Institutional Pharmacies b. Class II Institutional Pharmacies c. Modified Class II Institutional Pharm. d. Assisted

More information

4/8/2016. This knowledge based activity is accredited for 1.0 contact hour Target audience: Certified Pharmacy Technicians (CPhT)

4/8/2016. This knowledge based activity is accredited for 1.0 contact hour Target audience: Certified Pharmacy Technicians (CPhT) This knowledge based activity is accredited for 1.0 contact hour Target audience: Certified Pharmacy Technicians (CPhT) By Della Ata Khoury, CphT, BS, BA, MA Pharmacy Technician Instructor at LARE Institute

More information

Ensuring Healthcare Worker Safety When Handling Hazardous Drugs: The Joint Position Statement From the Oncology Nursing Society, the American

Ensuring Healthcare Worker Safety When Handling Hazardous Drugs: The Joint Position Statement From the Oncology Nursing Society, the American Ensuring Healthcare Worker Safety When Handling Hazardous Drugs: The Joint Position Statement From the Oncology Nursing Society, the American Society of Clinical Oncology, and the Hematology/Oncology Pharmacy

More information

To provide information about the role of the pharmacy in Infection Prevention and Control.

To provide information about the role of the pharmacy in Infection Prevention and Control. TITLE/DESCRIPTION: Pharmacy DEPARTMENT: Pharmacy PERSONNEL: Pharmacy Personnel EFFECTIVE DATE: 1/97 REVISED: 4/97, 7/08, 12/11, 1/15 I. PURPOSE To provide information about the role of the pharmacy in

More information

Jeanne Moldenhauer (c) Jeanne Moldenhauer

Jeanne Moldenhauer (c) Jeanne Moldenhauer Jeanne Moldenhauer (c) Jeanne Moldenhauer 2013 1 Presentation Overview Conflicts between regulatory and compendial guidance Understanding the requirements for non sterile and terminally sterilized products

More information

ASHP Guidelines on Evaluating and Using Home or Alternate-Site Infusion Service Providers

ASHP Guidelines on Evaluating and Using Home or Alternate-Site Infusion Service Providers Practice Settings Guidelines 515 ASHP Guidelines on Evaluating and Using Home or Alternate-Site Infusion Service Providers These guidelines describe the roles of home or alternatesite infusion service

More information

USP <797> PERSONAL HYGEINE PERSONAL PROTECTION EQUIPMENT

USP <797> PERSONAL HYGEINE PERSONAL PROTECTION EQUIPMENT USP PERSONAL HYGEINE PERSONAL PROTECTION EQUIPMENT PERSONAL HYGEINE PERSONAL PROTECTIVE EQUIPMENT Compounding personnel must maintain proper personal hygiene and use personal protective equipment

More information

USP <797>: Making the Case for Increasing Environmental Controls in Pharmaceutical Compounding. By Eric S. Kastango, M.B.A., R.Ph.

USP <797>: Making the Case for Increasing Environmental Controls in Pharmaceutical Compounding. By Eric S. Kastango, M.B.A., R.Ph. USP : Making the Case for Increasing Environmental Controls in Pharmaceutical Compounding By Eric S. Kastango, M.B.A., R.Ph., FASHP SUPPORTED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM HOSPIRA, INC.

More information

CHAPTER 17 STERILE PRODUCT COMPOUNDING 17-1

CHAPTER 17 STERILE PRODUCT COMPOUNDING 17-1 CHAPTER 17 STERILE PRODUCT COMPOUNDING 17-1 Sterile Product Compounding Reference: 1) United States Pharmacopeia chapter 797 (USP) 2) CMS: 482.25(b)(1) - All compounding, packaging, and dispensing

More information

Objectives. Reality Tech Check: Standardizing Certification of Pharmacy Technicians. Pre Test Question. Pre Test Question.

Objectives. Reality Tech Check: Standardizing Certification of Pharmacy Technicians. Pre Test Question. Pre Test Question. Reality Tech Check: Standardizing Certification of s Desi Kotis, Pharm.D., FASHP Brittany Huff, Pharm.D. The Speakers Have Nothing to Disclose Objectives Explain the value that s and pharmacy technicians

More information

Disclosures. Objectives. Leveraging and Developing Your Team for Optimal Outcomes. None

Disclosures. Objectives. Leveraging and Developing Your Team for Optimal Outcomes. None Leveraging and Developing Your Team for Optimal Outcomes Michelle W. McCarthy, PharmD, FASHP Coordinator, Pharmacy Education and Graduate Programs Charlottesville, VA November 6, 2017 Disclosures None

More information

CHAPTER 2 GENERAL PRACTICE OF PHARMACY REGULATIONS. These regulations are promulgated as authorized by the Act.

CHAPTER 2 GENERAL PRACTICE OF PHARMACY REGULATIONS. These regulations are promulgated as authorized by the Act. CHAPTER 2 GENERAL PRACTICE OF PHARMACY REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Purpose. The purpose of this regulation is to coordinate

More information

Radiopharmaceutical. Qualification. Checklist

Radiopharmaceutical. Qualification. Checklist Radiopharmaceutical Vendor Qualification Checklist section 1: RegulatoRy compliance Overview Nuclear pharmacies play an essential role in the preparation and distribution of radiopharmaceuticals for use

More information

Patient Safety Professional Program: Pre-work

Patient Safety Professional Program: Pre-work September 7, 2017 Postgraduate Institute for Medicine has agreed to jointly provide the continuing education activity listed below. This decision is taken upon review and acceptance of the application

More information

Department of Veterans Affairs Employee Education System

Department of Veterans Affairs Employee Education System DRAFT 6.30.09 Department of Veterans Affairs Employee Education System presents COURSE NO. 09.ST.PH.DIABCONF.A 2009 VETERANS AFFAIRS (VA) AND DEPARTMENT OF DEFENSE (DoD) DIABETES EDUCATORS CONFERENCE August

More information

D DRUG DISTRIBUTION SYSTEMS

D DRUG DISTRIBUTION SYSTEMS D DRUG DISTRIBUTION SYSTEMS JANET HARDING ORAL MEDICATION SYSTEMS Drug distribution systems in the hospital setting should ideally prevent medication errors from occurring. When errors do occur, the system

More information

Accreditation Commission for Health Care

Accreditation Commission for Health Care Questions Types of Accreditation Services Offered Does your organization have Medicare DMEPOS deemed status? (Yes/No) Is there an accreditation program for: (Yes/No) Yes Long Term Care (LTC) Pharmacy?

More information

Satellite Broadcast. VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care. FOR ALL DoD and VA: DATE:

Satellite Broadcast. VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care. FOR ALL DoD and VA: DATE: Satellite Broadcast VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care FOR ALL DoD and VA: DATE: Primary Care Staff CPG Implementation and Population Health

More information

CONTINUING PHARMACY EDUCATION (CPE) Project Planning Form for Live and Enduring Activities

CONTINUING PHARMACY EDUCATION (CPE) Project Planning Form for Live and Enduring Activities CONTINUING PHARMACY EDUCATION (CPE) Project Planning Form for Live and Enduring Activities More information about this form may be found at http://cpe.pharmacy.ufl.edu. NOTE: Minimum time before activity

More information

Improving Sterile Compounding: Impact of New Regulations, Standards and Guidelines PharMEDium Lunch and Learn Series LUNCH AND LEARN

Improving Sterile Compounding: Impact of New Regulations, Standards and Guidelines PharMEDium Lunch and Learn Series LUNCH AND LEARN LUNCH AND LEARN Improving Sterile Compounding: Impact of New Regulations, Standards and Guidelines September 9, 2016 Featured Speaker: Darryl S. Rich, PharmD, MBA, FASHP Medication Safety Specialist Institute

More information

CASE STUDY: PENINSULA REGIONAL MEDICAL CENTER

CASE STUDY: PENINSULA REGIONAL MEDICAL CENTER CASE STUDY: PENINSULA REGIONAL MEDICAL CENTER Incorporating IV room efficiencies while striving toward improving patient care 111852 2K 01/13 Page 1 of 5 OVERVIEW Peninsula Regional Medical Center (PRMC),

More information

Pharmaceutical Services Requirements: formerly 10D and 10C.7

Pharmaceutical Services Requirements: formerly 10D and 10C.7 Pharmaceutical Services Requirements: formerly 10D.28-29 and 10C.7 Frank S. Emanuel, Pharm.D., FASHP Associate Professor/Division Director Florida A and M University College of Pharmacy Jacksonville Disclosure

More information

2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question. Disclosures. Learning Objectives 3/16/2017

2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question. Disclosures. Learning Objectives 3/16/2017 2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question Nicole Allcock, PharmD, BCPS, FASHP Noelle RM Chapman, PharmD, BCPS, FASHP Joel Hennenfent, PharmD, MBA, BCPS, FASHP Jen

More information

Florida Department of Education Curriculum Framework PSAV

Florida Department of Education Curriculum Framework PSAV Florida Department of Education Curriculum Framework 2018 2019 Program Title: Program Type: Career Cluster: Pharmacy Technician Career Preparatory Health Science Program Number H170500 CIP Number 0351080506

More information

USP <800> and What Changes Will Mean for Oncology Practices November 2, 2016 State Society Education Series

USP <800> and What Changes Will Mean for Oncology Practices November 2, 2016 State Society Education Series USP and What Changes Will Mean for Oncology Practices November 2, 2016 State Society Education Series Willis C. Triplett, Pharm.D. Comply797 & Comply800 Learning Objectives 1. Understand USP s purported

More information

STATE OF FLORIDA DEPARTMENT OF HEALTH

STATE OF FLORIDA DEPARTMENT OF HEALTH DEPARTMENT OF HEALTH, STATE OF FLORIDA DEPARTMENT OF HEALTH PETITIONER, v. CASE NO. 2017-05245 SOUTHEAST COMPOUNDING PHARMACY, LLC, RESPON DENT. ADMINISTRATIVE COMPLAINT COMES NOW, Petitioner, Department

More information

Policies Approved by the 2017 ASHP House of Delegates

Policies Approved by the 2017 ASHP House of Delegates House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare

More information

US Compounding 2515 College Ave Conway, AR (800)

US Compounding 2515 College Ave Conway, AR (800) PCAB Compounding Accreditation Accreditation Summary US Compounding 2515 College Ave Conway, AR 72034 (800) 718 3588 www.uscompounding.com Date of Last In-Pharmacy Survey: June 2008 Next Scheduled In-Pharmacy

More information

University of Virginia Health System Department of Pharmacy Services PGY2 Drug Information Residency Residency Purpose Statement

University of Virginia Health System Department of Pharmacy Services PGY2 Drug Information Residency Residency Purpose Statement University of Virginia Health System Department of Pharmacy Services PGY2 Drug Information Residency Residency Purpose Statement Pharmacists completing this program will be equipped with the skills and

More information

Hospital and Other Healthcare Facilities

Hospital and Other Healthcare Facilities Hospital and Other Healthcare Facilities Council Progress Report December 2015 Judy Chong, RPh, BScPhm Manager, Hospital and Other Healthcare Facilities Agenda Background Drug Preparation Premises (DPPs)

More information

CHEMOTHERAPY/HAZARDOUS DRUGS PRECAUTIONS, PREPARATION, ORDERING

CHEMOTHERAPY/HAZARDOUS DRUGS PRECAUTIONS, PREPARATION, ORDERING CHEMOTHERAPY/HAZARDOUS DRUGS PRECAUTIONS, PREPARATION, ORDERING Naser Z. Alsharif, PharmD, PhD Professor, School of Pharmacy and Health Profeesions Creighton University, Omaha, NE Selected Slides Courtesy

More information

Implementation of Remote Management of Compounded Sterile Products through the use of a Telepharmacy System

Implementation of Remote Management of Compounded Sterile Products through the use of a Telepharmacy System Implementation of Remote Management of Compounded Sterile Products through the use of a Telepharmacy System Jerry Siegel Pharm.D., FASHP Howard Cohen M.S.,RPh FASHP Marianne Ivey Pharm.D., FASHP Safe Medication

More information

Use of Automation and Robotic Technology to Improve the Process for Preparing Compounded Sterile Products

Use of Automation and Robotic Technology to Improve the Process for Preparing Compounded Sterile Products Use of Automation and Robotic Technology to Improve the Process for Preparing Compounded Sterile Products Presented as a Live Webinar Monday, October 25, 2010 Planned and conducted by ASHP Advantage and

More information

Investigational Drug Service (IDS) Rotation Tool APPE Student Rotation

Investigational Drug Service (IDS) Rotation Tool APPE Student Rotation Investigational Drug Service (IDS) Rotation Tool APPE Student Rotation Rotation Description The goal of an IDS rotation is introduce students to the role the Investigation Drug Service (IDS) pharmacist

More information

Leveraging Nursing Expertise with USP<800>

Leveraging Nursing Expertise with USP<800> Leveraging Nursing Expertise with USP Martha Polovich, PhD, RN, AOCN Assistant Professor Byrdine F. Lewis College Of Nursing And Health Professions Disclosure Martha Polovich served as: A volunteer

More information

Accreditation Council for Pharmacy Education Accreditation Standards for Continuing Pharmacy Education

Accreditation Council for Pharmacy Education Accreditation Standards for Continuing Pharmacy Education Accreditation Council for Pharmacy Education Adoption: June 20, 2007 Released: October 5, 2007 Effective: January 1, 2009 Version 2: Released March 2014 Accreditation Council for Pharmacy Education Chicago,

More information

ADMINISTRATIVE CONTROLS FOR MANAGING HAZARDOUS DRUGS

ADMINISTRATIVE CONTROLS FOR MANAGING HAZARDOUS DRUGS ADMINISTRATIVE CONTROLS FOR MANAGING HAZARDOUS DRUGS TECHNICAL INFORMATION PAPER NO. 56-073-0417 PURPOSE This paper describes several administrative controls for the safe handling of hazardous drugs (HD):

More information

REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY

REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY Approved September 2014, Bangkok, Thailand, as revisions of the initial 2008 version. Overarching and Governance Statements 1. The overarching

More information

Environmental Engineering Lab User Information Sheet

Environmental Engineering Lab User Information Sheet Environmental Engineering Lab User Information Sheet Name Advisor / Dept Telephone # Email Address (cell phone preferred) Please sign that you have read and understand the General Notes on Lab Safety on

More information

STATE OF FLORIDA DEPARTMENT OF HEALTH

STATE OF FLORIDA DEPARTMENT OF HEALTH DEPARTMENT OF HEALTH, STATE OF FLORIDA DEPARTMENT OF HEALTH PETITIONER, v. CASE NO. 2017-06011 LINCOURT COMPOUNDING CENTER, LLC, RESPONDENT. ADMINISTRATIVE COMPLAINT COMES NOW, Petitioner, Department of

More information

ASHP Guidelines: Minimum Standard for Pharmaceutical Services in Ambulatory Care

ASHP Guidelines: Minimum Standard for Pharmaceutical Services in Ambulatory Care 428 Practice Settings Guidelines ASHP Guidelines: Minimum Standard for Pharmaceutical Services in Ambulatory Care In recent years there has been an increasing emphasis in health care on the provision of

More information

Improving the Patient Experience Through Pharmacy

Improving the Patient Experience Through Pharmacy Rick Burnett Chief Operating Officer Kenneth Maxik Director, Patient Safety & Pharmacy Compliance Improving the Patient Experience Through Pharmacy August 19, 2015 Speakers Rick Burnett, PharmD, FACHE

More information

Pharmacy Sterile Compounding Areas

Pharmacy Sterile Compounding Areas Approved by: Pharmacy Sterile Compounding Areas Corporate Director, Environmental Supports Environmental Services/ Nutrition Food Services Operating Standards Manual Number: Date Approved June 17, 2016

More information

Introduction to Pharmacy Practice

Introduction to Pharmacy Practice Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians

More information

ASHP Guidelines on Compounding Sterile Preparations

ASHP Guidelines on Compounding Sterile Preparations Drug Distribution and Control: Preparation and Handling Guidelines 111 ASHP Guidelines on Compounding Sterile Preparations Purpose The compounding of medications is a fundamental part of pharmacy practice.

More information

CASPER COLLEGE COURSE SYLLABUS. Pharmacy Simulation Laboratory II PHTK 1610 H1. Office Phone: Office: LH 104

CASPER COLLEGE COURSE SYLLABUS. Pharmacy Simulation Laboratory II PHTK 1610 H1. Office Phone: Office: LH 104 CASPER COLLEGE COURSE SYLLABUS Pharmacy Simulation Laboratory II PHTK 1610 H1 Semester/Year: Spring 2018 Lecture Hours: 2 Lab Hours: 4 Credit Hours: 4 Class Time: 2-6 p.m. Days: Wednesday Room: LH 103

More information

PACKAGING, STORAGE, INFECTION CONTROL AND ACCOUNTABILITY (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

PACKAGING, STORAGE, INFECTION CONTROL AND ACCOUNTABILITY (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO: LESSON PLAN: 7 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,

More information

USP <800>: Navigating the New Requirements for Handling Hazardous Drugs in the Community Oncology Setting

USP <800>: Navigating the New Requirements for Handling Hazardous Drugs in the Community Oncology Setting USP : Navigating the New Requirements for Handling Hazardous Drugs in the Community Oncology Setting Exploratory Paper Nina K. Chavez, MBA, SPHR, FACMPE August 22, 2017 This paper is being submitted

More information

Look WHAT They ve Done to Us: Law Update 2014 October 2014 Greg Baran B.S. Pharm., M.A., FMPA

Look WHAT They ve Done to Us: Law Update 2014 October 2014 Greg Baran B.S. Pharm., M.A., FMPA Look WHAT They ve Done to Us: Law Update 2014 October 2014 Greg Baran B.S. Pharm., M.A., FMPA Objectives: At the completion of this program, participants will be able to: 1. Recognize the changes made

More information

2016 Plan of Correction Data 1

2016 Plan of Correction Data 1 2016 Plan of Correction Data 1 Retail Data Calendar Year 2015 2016 Number of Inspections 1263 1694 number of Plan of Correction s (POC s) issued 502 523 Regulatory Citations 2 & 2015 2016 number of POC

More information

PCAB Compounding Accreditation Accreditation Summary

PCAB Compounding Accreditation Accreditation Summary PCAB Compounding Accreditation Accreditation Summary McGuff Compounding Pharmacy Services, Inc Santa Ana, California compounding pharmacy 2921 W. MacArthur Blvd., Ste.142 Santa Ana, CA 92704 Telephone:877-444-1133

More information

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER INTRODUCTORY RULES TABLE OF CONTENTS

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER INTRODUCTORY RULES TABLE OF CONTENTS RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-01 INTRODUCTORY RULES TABLE OF CONTENTS 1140-01-.01 Definitions 1140-01-.02 Violations Constitute Unprofessional Conduct 1140-01-.03 Application for

More information

Pharmacy General Personnel

Pharmacy General Personnel Pharmacy The Pharmacy Department is an important area for infection control because its products are potentially dispensed to all patients. Contamination of medications or other pharmaceuticals whether

More information

On January 1, 2004, chapter 797

On January 1, 2004, chapter 797 Impact of United States Pharmacopeia chapter 797: Results of a national survey On January 1, 2004, chapter 797 of the United States Pharmacopeia (USP) became the nation s first enforceable standard for

More information

Accreditation of Hospital Pharmacies Update

Accreditation of Hospital Pharmacies Update Accreditation of Hospital Pharmacies Update Ontario Hospital Pharmacy Management Seminar May 28, 2017 Judy Chong, RPh, BScPhm Manager, Hospital Practice Presenter Disclosure I have no current or past relationships

More information

Department Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual

Department Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual Department Policy Code: D: MM-5615 Entity: Fairview Pharmacy Services Department: Fairview Home Infusion Manual: Policy and Procedure Manual Category: Home Infusion Subject: Chemotherapy Purpose: Ensure

More information

ONCOLOGY PRACTICE MANAGEMENT

ONCOLOGY PRACTICE MANAGEMENT ONCOLOGY PRACTICE MANAGEMENT Christopher A. Fausel, Pharm.D., MHA, BCOP Clinical Manager, Oncology Pharmacy Chair, Hoosier Cancer Research Network Indiana University Simon Cancer Center Indianapolis, Indiana

More information

EHR] A INSPECTION REPORT. Guy s Hospital Pharmacy St Thomas Street London SE1 9RT. Safeguarding public health

EHR] A INSPECTION REPORT. Guy s Hospital Pharmacy St Thomas Street London SE1 9RT. Safeguarding public health Safeguarding public health EHR] A INSPECTION REPORT Guy s Hospital Pharmacy St Thomas Street London SE1 9RT Head Office: Inspection & Standards Division, Market Towers, I Nine Elms Lane, Vauxhall, London,

More information

emedcert Internet CME Requirements

emedcert Internet CME Requirements emedcert Internet CME Requirements Release Date: March 25, 2015 Expiration Date: December 31, 2018 Estimated time to complete activity: 6.0 / 4.0 hours for certification / recertification To contact the

More information

Institutional Pharmacy

Institutional Pharmacy Institutional Pharmacy Course Outline Hospital Pharmacy! Technician Roles! Hospital Pharmacy Areas! Organization of Medications! Hospital Formulary! Unit Dose System! Communication Computer Systems Medical

More information